These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2418116)

  • 1. Serologic and T cell recognition of truncated transplantation antigens encoded by in vitro deleted class I major histocompatibility genes.
    McCluskey J; Bluestone JA; Coligan JE; Maloy WL; Margulies DH
    J Immunol; 1986 Feb; 136(4):1472-81. PubMed ID: 2418116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants.
    McCluskey J; Boyd L; Foo M; Forman J; Margulies DH; Bluestone JA
    J Immunol; 1986 Dec; 137(12):3881-90. PubMed ID: 2431046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells.
    Stroynowski I; Clark S; Henderson LA; Hood L; McMillan M; Forman J
    J Immunol; 1985 Sep; 135(3):2160-6. PubMed ID: 2410513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The products of transferred H-2 genes express determinants that restrict hapten-specific cytotoxic T cells.
    Levy RB; Richardson JC; Margulies DH; Evans GA; Seidman JG; Ozato K
    J Immunol; 1983 Jun; 130(6):2514-8. PubMed ID: 6189891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular localization of allogeneic and self determinants recognized by bulk and clonal populations of cytotoxic T cells.
    Levy RB; Ozato K; Richardson JC; Bluestone JA
    J Immunol; 1985 Feb; 134(2):677-83. PubMed ID: 2578159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.
    Margulies DH; Evans GA; Ozato K; Camerini-Otero RD; Tanaka K; Appella E; Seidman JG
    J Immunol; 1983 Jan; 130(1):463-70. PubMed ID: 6571712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface expression of an in vitro recombinant class II/class I major histocompatibility complex gene product.
    McCluskey J; Germain RN; Margulies DH
    Cell; 1985 Feb; 40(2):247-57. PubMed ID: 2578320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of hybrid H-2 genes for localizing the positions of polymorphic determinants recognized by antibodies and by cytotoxic T cells.
    Ozato K; Evans GA; Margulies DH; Seidman JG; Levy RB
    Transplant Proc; 1983 Dec; 15(4):2074-6. PubMed ID: 6200975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of novel class I histocompatibility antigens by interspecies exon shuffling.
    Engelhard VH; Yannelli JR; Evans GA; Walk SF; Holterman MJ
    J Immunol; 1985 Jun; 134(6):4218-25. PubMed ID: 2985705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha-3 domain of class I MHC proteins influences cytotoxic T lymphocyte recognition of antigenic determinants located within the alpha-1 and alpha-2 domains.
    Maziarz RT; Burakoff SJ; Bluestone JA
    J Immunol; 1988 Jun; 140(12):4372-7. PubMed ID: 2453580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens.
    Stroynowski I; Forman J; Goodenow RS; Schiffer SG; McMillan M; Sharrow SO; Sachs DH; Hood L
    J Exp Med; 1985 May; 161(5):935-52. PubMed ID: 2580938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR; Koszinowski UH; Eichmann K; Melchers I
    J Immunol; 1989 Dec; 143(12):4238-43. PubMed ID: 2556481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of murine major histocompatibility Class I antigen: assignment of putative allodeterminants to distinct positions of the amino acid sequence within the first external domain of the antigen.
    Ozato K; Takahashi H; Appella E; Sears DW; Murre C; Seidman JG; Kimura S; Tada N
    J Immunol; 1985 Mar; 134(3):1749-58. PubMed ID: 2578519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mutant H-2d proteins encoded by class I genes which alternatively process the 5' end of their transcripts.
    Hedley ML; Ozato K; Maryanski J; Tucker PW; Forman J
    J Immunol; 1989 Aug; 143(3):1026-31. PubMed ID: 2473108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface expression of the amino-terminal domain of A kappa alpha. Recognition of an isolated MHC antigenic structure by allospecific T cells but not alloantibodies.
    McCluskey J; Munitz T; Boyd L; Germain RN; Coligan JE; Singer A; Margulies DH
    J Immunol; 1988 Mar; 140(6):2081-9. PubMed ID: 2450139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A third class I major histocompatibility complex antigen encoded by a gene in the D region of the H-2d haplotype recognized by cytotoxic T lymphocytes.
    Mann DW; Forman J
    Immunogenetics; 1988; 28(1):38-45. PubMed ID: 3259946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.
    Maryanski JL; Accolla RS; Jordan B
    J Immunol; 1986 Jun; 136(12):4340-7. PubMed ID: 3086429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of the H-2D region using a new intra-D-region recombinant mouse strain.
    Duran LW; Zeller JC; Lundy JK; Chang-Miller A; Krco CJ; David CS; Pease LR
    J Immunol; 1987 Oct; 139(8):2818-24. PubMed ID: 3309060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P; Leidig S; Heckl-Oestreicher B
    Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.